07:00 , Aug 13, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: HECT domain containing E3 ubiquitin protein ligase 2 (HECTD2)

Inflammation INDICATION: Inflammation; pulmonary Mouse studies suggest inhibiting HECTD2 could help treat lung inflammation. In a mouse model of pneumonia, pretreatment with a lentiviral vector encoding HECTD2 increased lung inflammation compared with a control vector, whereas lung-specific...
08:00 , Mar 5, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Infectious disease

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Infectious disease ...